Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Back
Evaluation ViewAttendees 42

Core Curriculum for Fellows

Critical Care

Emergency Medicine

General Pediatrics

Hospital Medicine

Infectious Diseases

Pharmacology and Therapeutics

Trainee
Session Type: Hot Topic Symposia

Putting the 'pnew' in pneumonia

Saturday, April 26, 2025
7:00am – 8:30am HST
Location: Convention Center: 313 A
CE: 1.5

Selected By: PIDS
Co-sponsored By: PHM
Disclosure(s):
Jillian Cotter, MD, MSCS: Pfizer Inc (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

This proposed hot topic symposia will be focused on the latest research evidence, expert perspectives, and unanswered questions related to the diagnosis and management of pediatric community-acquired pneumonia (CAP), which remains the leading cause of morbidity and mortality for children globally. In particular, the proposed session will focus on the utility of biomarkers (e.g., CBC, CRP, procalcitonin, the novel MeMed Bacterial vs. Viral test) in the initial diagnosis of bacterial vs. viral CAP and their role in monitoring of children with pneumonia, new developments in invasive and non-invasive modalities for molecular detection of pneumonia pathogens (e.g., lower respiratory tract and pleural fluid syndromic vs. targeted PCRs, metagenomic microbial cell-free DNA sequencing), and updates in the antimicrobial treatment of CAP (e.g., oral vs. IV treatment, duration of antibiotics for uncomplicated and complicated CAP). The session will cover both mild cases of CAP that can be managed in an outpatient setting and severe, complicated CAP requiring surgical intervention. We expect the session will be engaging for a diverse group of conference attendees at all levels of experience, including inpatient and outpatient clinicians, trainees, pharmacists, researchers, and epidemiologists.

Learning Objectives:

  • Consider the role of conventional and novel biomarkers in the diagnosis and monitoring of children with community-acquired pneumonia
  • Describe the landscape of new advanced molecular diagnostics for pneumonia pathogen detection and discuss the challenges and opportunities for diagnostic stewardship of new tests
  • Discuss new trends and shifts in the antimicrobial treatment of bacterial community-acquired pneumonia and consider how these updates may impact clinical practice

Presentations:

  • 7:00am – 7:05am HST
    Introductions

    Speaker: Jillian Cotter, MD, MSCS (she/her/hers) – University of Colorado School of Medicine

  • 7:05am – 7:30am HST
    Clinical Utility of Traditional and Novel Biomarkers in the Diagnosis and Management of Community-acquired Pneumonia

    Speaker: Denver Niles, MD, D(ABMM) (he/him/his) – Baylor College of Medicine

  • 7:55am – 8:20am HST
    Molecular Diagnostic Testing for Complicated Community-acquired Pneumonia: Opportunities and Challenges

    Speaker: Erin Ho, MD (she/her/hers) – University of Colorado School of Medicine

  • 7:55am – 8:20am HST
    Updates in the Treatment of Community-acquired Pneumonia

    Speaker: Michael J. Bozzella, DO, MS (he/him/his) – Children's Hospital Colorado/University of Colorado School of Medicine

  • 8:20am – 8:30am HST
    Q & A

    Speaker: Michael J. Bozzella, DO, MS (he/him/his) – Children's Hospital Colorado/University of Colorado School of Medicine